Tiffany Chen, MD
Otolaryngology · New Haven, CTNPI 1548603525
Payments from drug & device makers
What this record shows
Intersect ENT, Inc. accounts for 71.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $2,394 and has fallen 80.0% since, to $479 in 2025.
Across 51 payments — averaging $63.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$2K
- GSK$321
- Sanofi$205
- Regeneron Healthcare Solutions, Inc.$166
- Medtronic$114
- Johnson & Johnson$81
- plus $48 from 2 others
What the payments were for
- Travel & lodging$1,47245%
- Food & beverage$1,77755%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 11 | $2,313 |
| GSK | 20 | $321 |
| Sanofi | 9 | $205 |
| Regeneron Healthcare Solutions, Inc. | 6 | $166 |
| Medtronic | 1 | $114 |
| Johnson & Johnson | 1 | $81 |
| Optinose US, Inc. | 2 | $32 |
| AstraZeneca | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SINUVA$2,036
- PROPEL$141
- Reveal LINQ$114
How this compares
$3,249 in reported general payments places this provider in the 70th percentile of 119 otolaryngology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 52 | $194,287 |
| Azelastine Hcl | 103 | $2,987 |
| Fluocinolone Acetonide Oil | 28 | $1,270 |
| Ipratropium Bromide | 48 | $648 |
| Fluticasone Propionate | 44 | $592 |
| Triamcinolone Acetonide | 22 | $555 |
| Ofloxacin | 46 | $538 |
| Montelukast Sodium | 67 | $435 |
| Clotrimazole | 13 | $423 |
| Pantoprazole Sodium | 45 | $342 |
| Mupirocin | 51 | $341 |
| Meclizine Hcl | 12 | $224 |
| Betamethasone Valerate | 20 | $204 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $199 |
| Omeprazole | 22 | $165 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in New Haven
- Sara PaiNew Haven$160K
- Richard ManesNew Haven$67K
- Howard BoeyNew Haven$19K
- Wendell YarbroughNew Haven$6K
- Ken YanagisawaNew Haven$5K
- Mark DagostinoNew Haven$5K
- Clarence SasakiNew Haven$5K
- Eaton ChenNew Haven$4K
- Catherine BrophyNew Haven$3K
- Paul FortgangNew Haven$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.